澳洋健康(002172) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥543,869,982.70, a decrease of 15.49% compared to ¥643,577,490.50 in the same period last year[3] - Net profit attributable to shareholders was ¥36,326,684.73, representing an increase of 11.78% from ¥32,498,869.97 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥11,677,474.17, down 70.62% from ¥39,746,660.40 in the previous year[3] - Basic and diluted earnings per share increased by 25.00% to ¥0.05 from ¥0.04 year-on-year[3] - Total operating revenue for Q1 2023 was CNY 543.87 million, a decrease of 15.5% compared to CNY 643.58 million in Q1 2022[15] - Net profit for Q1 2023 reached CNY 36.66 million, an increase of 11.4% from CNY 32.79 million in Q1 2022[16] - The company's total assets decreased to CNY 2.55 billion in Q1 2023 from CNY 2.71 billion in Q1 2022, a decline of 5.8%[12] - The company's equity attributable to shareholders increased to CNY 80.59 million in Q1 2023 from CNY 44.26 million in Q1 2022, a growth of 82%[13] Cash Flow and Liquidity - The net cash flow from operating activities improved by 62.46%, reaching -¥121,279,156.93 compared to -¥323,103,011.47 in the same period last year[3] - The net cash flow from financing activities decreased by 95.20% compared to the previous year, attributed to no inter-company borrowing repayments during the period[8] - The net increase in cash and cash equivalents decreased by 227.27% year-on-year, primarily due to a significant increase in cash from the disposal of long-term assets in the previous period[8] - The cash and cash equivalents at the end of the reporting period were 722,967,577.03 yuan, down from 984,155,292.34 yuan at the beginning of the year[11] - The company’s cash and cash equivalents decreased to CNY 744.11 million in Q1 2023 from CNY 755.60 million in Q1 2022[12] - Total cash inflow from financing activities was 551,934,820.35 CNY, while cash outflow was 567,103,261.31 CNY, resulting in a net cash flow of -15,168,440.96 CNY[19] - Cash received from sales of goods and services was 496,348,199.74 CNY, a decrease from 533,277,746.93 CNY year-over-year[18] Investment and Assets - Investment income for the period was ¥25,827,820.99, a significant increase from a loss of ¥142,691.76 in the same period last year[6] - The company recognized a non-recurring gain of 25,827,820.99 yuan from the sale of its wholly-owned subsidiary, Jiangsu Aoyang New Materials Technology Co., Ltd.[9] - The total current assets at the end of the reporting period amounted to 1,651,777,974.50 yuan, down from 1,808,681,669.58 yuan at the beginning of the year[11] - The balance of accounts receivable increased to 394,589,122.04 yuan from 314,453,133.56 yuan at the beginning of the year[11] - The company reported a total cash inflow from operating activities of 680,114,077.87 CNY, down from 750,511,190.57 CNY in the previous period[18] - The company’s cash flow from investment activities showed a net outflow of -19,806,545.73 CNY, contrasting with a net inflow of 761,728,828.43 CNY in the previous period[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 63,763[8] - The largest shareholder, Aoyang Group Co., Ltd., holds 30.74% of shares, amounting to 235,349,599 shares, with 116,686,547 shares pledged[8] Costs and Expenses - Total operating costs for Q1 2023 were CNY 524.02 million, down 19.6% from CNY 651.94 million in the same period last year[15] - The company experienced a 71.62% reduction in financial expenses due to a decrease in total borrowings and corresponding interest expenses[6] - Cash used for debt repayment decreased by 60.12% compared to the same period last year, primarily due to a reduction in loan repayment amounts[8] - Cash paid for dividends and interest increased by 67.88% year-on-year, mainly due to an increase in dividends paid to minority shareholders[8] - The company paid 551,296,828.73 CNY for purchasing goods and services, down from 845,188,472.01 CNY in the previous period[18] - The cash outflow for other investment activities was 25,987,067.34 CNY, compared to 189,074,637.19 CNY in the previous period[19]